Trading: SELL @ $0.25
Signal Strength: STRONG
Indicator is best used in conjunction with additional indicators as it has the ability to highlight potential overbought or oversold levels. This indicator utilizes upper and lower bands to visually represent price extremes associated with the bands. Additional value can be added to the trading strategy by accessing divergences between price and volume.
Cogstate (ASX:CGS) is currently bearish highlighting the potential for a short term trend continuation in the downward direction.
The Donchian channel is a useful indicator for seeing the volatility of a market price. If a price is stable the Donchian channel will be relatively narrow. If the price fluctuates a lot the Donchian channel will be wider. The two outer bands are plotted as the highest high and lowest low for a set period originally 20 days with the optional middle band calculated as the average of the two.
Calculation: Donchian Channels:
1) Upper Channel = 20 Day High;
2) Lower Channel = 20 Day Low;
3) Middle Channel = (20 Day High + 20 Day Low)/2;
PROFILE: Cogstate (CGS.AX)
Stock Exchange: ASX
Ticker Codes: | CGS.AX | ASX:CGS |
Cogstate Limited, a cognitive science company, provides computerized cognitive tests for clinical trials, academic research, healthcare, and brain injury applications primarily in Australia, the United States, and Europe. The company's services include scientific consultancy, project management, data management, statistical analysis, and reporting. It operates in three segments: Clinical Trials, Academic Research, and Healthcare. The Clinical Trials segment provides technology and associated services that are used to quantify the effect of disease and drugs, and devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical and biotechnology companies. The Academic Research segment offers technology and associated services to support international research studies and academic collaborations. As of June 30, 2017, it had participated in approximately 1,200 academic research studies in approximately 70 indications. The Healthcare segment provides Cognigram, a system that enables regular and standardized assessment of patients to detect cognitive decline. The company serves biopharmaceutical companies, sporting organizations, military, physicians and patients, academic institutions, and public-private partnerships. Cogstate Limited was founded in 1999 and is headquartered in Melbourne, Australia.
|EVO Evolve Education||0.22||7.5||274,166||-4.55||BEARISH|
|GGG Greenland Minerals||0.06||5.8||1,288,826||-3.85||BEARISH|
|BRN Brainchip Holdings||0.06||4.9||803,599||-16.67||BEARISH|
|FBR Fastbrick Robotics||0.1||4.2||3,467,558||-20.45||BEARISH|
|ATL ASX 20||0.95||3.3||194,890||-25||BEARISH|
|MOY Millennium Minerals||0.17||3||1,042,716||-30||BEARISH|
|AAC Australian Agricultural||0.96||2.7||986,258||-10.53||BEARISH|
|CGF Challenger Financial Services||7.93||2.5||2,007,772||-9.74||BEARISH|
|OZL Oz Minerals||10.29||2.2||1,861,972||-6.68||BEARISH|